Surrozen, Inc./DE (SRZN) Insider Trading Disclosures
Surrozen, Inc./DE (SRZN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SRZN
CIK: 1824893
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerArusa Malik
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001213900-26-107661 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-10-02 | 8-K | 0001193125-26-411298 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-01 | — | SCHEDULE 13G Filing | 0001831942-26-000044 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000905148-26-003732 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001213900-26-090021 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-096754 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-11 | — | SCHEDULE 13G/A Filing | 0001873545-26-000005 | View SEC Doc Filr Page |
| 25-NSE | 2026-08-07 | — | 25-NSE Filing | 0001354457-26-000770 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338120 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338068 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-24 | — | SCHEDULE 13G/A Filing | 0001193125-26-316577 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-22 | 4 | 0001193125-26-316570 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-15 | 4 | 0001193125-26-272796 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-15 | 4 | 0001193125-26-272780 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-15 | 4 | 0001193125-26-272765 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-15 | 4 | 0001193125-26-272754 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-13 | 4 | 0001193125-26-230953 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-18 | — | SCHEDULE 13D/A Filing | 0001193125-26-227857 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062678 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001738048-26-000056 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-226874 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001873545-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001213900-26-057691 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-061993 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-13 | 4 | 0001193125-26-224286 | View SEC Doc Filr Page |